By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
Kerry Blatney is an Analyst at Brighton Park Capital. Her primary responsibilities include thematic research, deal sourcing, and completing due diligence on prospective investments.
Prior to joining BPC in July of 2022, Kerry completed a summer internship at Pfizer in Technology Transformation for their Safety and Regulatory Affairs divisions. Additionally, she has been involved in preclinical and clinical research at several academic institutions. Kerry graduated from the School of Engineering and Applied Science at the University of Pennsylvania with a BSE in Bioengineering and an MS in Biotechnology.
Education
University of Pennsylvania
Ask Me About
How technology is enabling personalized medicine and accelerating drug discovery
My favorite castles in France
The best ways to pass time while training for long distance races
